Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003796149 | SCV004580497 | pathogenic | GNE myopathy; Sialuria | 2023-03-04 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with GNE-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Ile92Asnfs*15) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). |
Baylor Genetics | RCV004573321 | SCV005059613 | likely pathogenic | GNE myopathy | 2024-02-14 | criteria provided, single submitter | clinical testing |